Sinopharm Group (SHTDF) News Today → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free SHTDF Stock Alerts $2.82 0.00 (0.00%) (As of 05/30/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsShort InterestStock AnalysisChartFinancialsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 1:24 AM | americanbankingnews.comCritical Review: Cardinal Health (NYSE:CAH) and Sinopharm Group (OTCMKTS:SHTDF)April 29, 2024 | marketwatch.comSinopharm Group Shares Fall as Higher Costs Cut Into Quarterly ProfitApril 6, 2024 | morningstar.comSinopharm Group Co Ltd ADR X2S1February 21, 2024 | morningstar.comSinopharm Group Co Ltd 01099January 30, 2024 | morningstar.comSinopharm Group Co Ltd X2SNovember 8, 2023 | morningstar.comSinopharm Group Co Ltd SHTDFMay 12, 2023 | msn.comSinopharm Group (HKEX:1099) Price Target Increased by 8.31% to 29.48April 13, 2023 | finance.yahoo.comPfizer signs strategic cooperation pact with China's SinopharmApril 6, 2023 | msn.comWHO chief expects COVID emergency to end this yearMarch 24, 2023 | msn.comChina approves its first mRNA Covid-19 vaccineMarch 22, 2023 | news.yahoo.comChina approves first home-grown mRNA Covid vaccineFebruary 23, 2023 | forbes.comSinopharm GroupJanuary 20, 2023 | news.yahoo.comSinopharm unit gets OK for clinical trials of mRNA COVID vaccineJanuary 20, 2023 | msn.comPharma major Sinopharm gets approval for clinical trials of mRNA Covid-19 vaccineDecember 8, 2022 | reuters.comSinopharm's second Chinese herb shot is potentDecember 2, 2022 | seekingalpha.comVaxxinity says COVID vaccine outperformed Astra and Sinopharm shots as boosterSeptember 28, 2022 | seekingalpha.comMerck in pact with Sinopharm to launch oral COVID-19 therapy in ChinaSeptember 15, 2022 | msn.comSinopharm to boost local COVID vaccine production in AfricaSeptember 7, 2022 | msn.comChina’s Sinovac to test Omicron-targeting vaccines in ChileJuly 27, 2022 | msn.comDaesang to set up joint venture with China Sinopharm InternationalJuly 17, 2022 | seekingalpha.comWeek In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology InvestmentsJuly 4, 2022 | msn.comHong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by DecemberJune 27, 2022 | msn.comChina Donates 10 Mil Doses of Sinopharm COVID-19 Vaccines, SyringesJune 22, 2022 | usnews.comSome Omicron Sub-Variants Escaping Antibodies From Sinopharm Shot -Chinese StudyJune 21, 2022 | reuters.comSome Omicron sub-variants escaping antibodies from Sinopharm shot - Chinese studyMay 31, 2022 | msn.comUniversity of Hong Kong, Sinopharm launch city’s first trial for Omicron-targeting vaccine which could be ready in NovemberMay 28, 2022 | seekingalpha.comCanSino's Covid Vaccine Gets WHO Nod. But Is It Too Little, Too Late?April 18, 2022 | seekingalpha.comSinovac Biotech's Omicron-specific vaccine cleared for clinical trial in Hong KongApril 16, 2022 | msn.comSinopharm, Sinovac vaccine candidates for Omicron variant gets clearance for clinical trialApril 3, 2022 | bloomberg.comSinopharm Says Second-Generation Vaccine Approved for TrialFebruary 22, 2022 | reuters.comAntibody triggered by Sinopharm COVID booster wanes after six months - studyFebruary 9, 2022 | msn.comAbu Dhabi makes fourth doses of Pfizer and Sinopharm Covid-19 vaccines availableFebruary 8, 2022 | msn.comAll required data received for Sinopharm vaccine to be registered - SahpraFebruary 7, 2022 | msn.comSahpra registers Sinopharm, Pfizer COVID-19 vaccines for use in SAJanuary 14, 2022 | nasdaq.comSinopharm Group Co Ltd (SHTDF)January 7, 2022 | msn.comDuterte receives Sinopharm COVID-19 boosterJanuary 5, 2022 | msn.comWHO: shots such as Sinopharm and Sinovac prevent 'severe hospitalisation' from OmicronOctober 15, 2021 | msn.comSinopharm Covid-19 vaccine now available in MalaysiaOctober 15, 2021 | msn.comSinopharm vaccine now available at GPs, private hospitalsOctober 12, 2021 | msn.comWHO group backs third Covid-19 shot for elderly vaccinated with Sinovac or SinopharmSeptember 29, 2021 | businesswire.comChromaDex Partners with Sinopharm Xingsha for Cross-Border Sales of Tru Niagen® into Mainland ChinaSeptember 9, 2021 | msn.comChina’s Sinopharm Group contemplates vaccine plant in SLSeptember 8, 2021 | msn.comDuopharma denies appointing Bintai Healthcare, other parties as distributor of Sinopharm's Covid-19 vaccineAugust 29, 2021 | wsj.comSinopharm Covid Vaccine Seen as Less Effective in Bahrain StudyAugust 29, 2021 | msn.comCuba to deploy China's Sinopharm alongside homegrown vaccinesAugust 25, 2021 | msn.comCoronavirus: Sinopharm’s twin approach to variants aims for improved vaccine while testing booster shotAugust 24, 2021 | msn.comSinopharm executive suggests vaccinated people accept booster shots after China builds herd immunity - Global TimesAugust 23, 2021 | msn.comSinopharm vaccine gets EUA from FDAAugust 21, 2021 | msn.comDuterte thanks China for giving 1M doses of Sinopharm vaccineAugust 18, 2021 | msn.comGLOBALink | Bangladesh signs agreement to manufacture China's Sinopharm COVID-19 inactivated vaccine Get Sinopharm Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"... CLICK HERE TO GET YOUR GUIDE NOW SHTDF Media Mentions By Week SHTDF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHTDF News Sentiment▼0.500.82▲Average Medical News Sentiment SHTDF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHTDF Articles This Week▼20▲SHTDF Articles Average Week Get Sinopharm Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CAKFY News Today KOSK News Today SHTDY News Today TGIFF News Today FFNTF News Today ABSCF News Today ACONW News Today ACRHF News Today ACRDF News Today ADMT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SHTDF) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks MediaElon Musk’s Final Masterpiece: “X-9840”Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
